side effects of glp 1 oral Adverse GLP-1 Receptor Agonists Rx Trends: Real-World Data on

GLP-1 (glucagon-like peptide-1) receptor agonists are a class of medications originally developed to help people with diabetes control blood sugar

This reference compiles what published primary sources currently say about retatrutide in the context of obesity research, covering the mechanism, Phase 2 and Phase 3 trial data, the reported side-effect profile, the current FDA regulatory status, and laboratory considerations that apply when suppliers provide the compound as a research reference standard

Retatrutide could get approved soon and be available for people to use

Without insurance, semaglutide costs between $968.52 and $1,349.02 per month

doi:10.1172/JCI112936 149